腸炎を助長する環境要因の特定
Liliana M Sanmarco1, Chun-Cheih Chao1, Yu-Chao Wang2
1Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Nature
|October 20, 2022
まとめ
プロピザミドのような環境要因は 炎症性腸疾患 (IBD) を悪化させる可能性があります 新しいシステムアプローチにより,プロピザミドが標的とする免疫細胞の重要なシグナル伝達経路が特定され,IBDの病原性に関する洞察が提供されました.
科学分野:
- 胃腸内科と免疫学
- 環境 健康
- コンピュータ生物学
背景:
- 炎症性腸疾患 (IBD) は慢性的な胃腸疾患で,その罹患率は増加しています.
- 遺伝的要因だけでは IBD を説明することはできません.環境の影響は重要ですが,十分に理解されていません.
- 現存する研究プラットフォームには IBDの環境的なトリガーを特定するための体系的な方法がない.
研究 の 目的:
- IBDの環境要因を特定するための統合システムアプローチを開発し,適用する.
- 環境要因が腸の炎症に影響を与えるメカニズムを解明する.
- IBDおよび関連する炎症性疾患の新たな治療目標を発見する.
主な方法:
- 組み合わせた公共データベース ゼブラフィッシュ化学スクリーン 機械学習 マウスモデル
- システム生物学パイプラインを利用し,環境トリガーの高通量識別を行いました.
- 環境に起因する炎症に関与する分子信号伝達経路を調査した.
主要な成果:
- 腸の炎症を悪化させる要因として 除草剤プロピザミドを特定した
- 免疫細胞におけるアリル炭化水素受容体 (AHR) - 核因子カッパB (NF-κB) - CCAAT増強剤-結合タンパク質β (C/EBPβ) 信号軸を明らかにした.
- プロピザミドは,このAHR-NF-κB-C/EBPβ経路を標的にして炎症を促進することを実証した.
結論:
- IBDの環境要因を発見するための強力なパイプラインを開発しました.
- 腸の炎症に重要な 免疫細胞の信号伝達経路を発見した
- 他の炎症性疾患における環境要因とメカニズムを特定するための枠組みを提供した.
関連する概念動画
Irritable Bowel Syndrome I: Introduction
351
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
351
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
393
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
393
Inflammatory Bowel Disease I: Ulcerative Colitis
294
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
294
Chronic Bowel Disorders: Introduction
525
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
525
Anatomy of the Intestines
73.0K
Although digestion of proteins, carbohydrates, and lipids may begin in the stomach, it is completed in the intestine. The absorption of nutrients, water, and electrolytes from food and drink also occurs in the intestine. The intestines can be divided into two structurally distinct organs—the small and large intestines.
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
73.0K
Inflammatory Bowel Disease II: Crohn's Disease
349
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
349


